Bruker Corp (OQ:BRKR)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 40 MANNING RD
BILLERICA MA 01821
Tel: N/A
Website: https://www.bruker.com
IR: See website
<
Key People
Frank H. Laukien
Chairman of the Board, President, Chief Executive Officer
Gerald N. Herman
Chief Financial Officer, Executive Vice President
Falko Busse
President, Bruker BioSpin Group
Burkhard Prause
President and Chief Executive Officer, Bruker Energy and Supercon Technologies, Inc
Juergen Srega
President of Bruker CALID Group and Bruker Daltonics Division
Mark Robert Munch
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Business Overview
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company's BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It offers scanning transmission electron microscopes (STEM). It also offers advanced research Raman microscopy systems.
Financial Overview
For the fiscal year ended 31 December 2023, Bruker Corp revenues increased 17% to $2.96B. Net income increased 44% to $427.2M. Revenues reflect BSI NANO segment increase of 20% to $941.9M, BSI CALID segment increase of 17% to $960.4M, BSI BioSpin segment increase of 15% to $798.5M, China segment increase of 33% to $528.1M, Europe segment increase of 18% to $699.7M, United States segment increase of 12% to $777.7M.
Employees: 9,707 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $13,726M as of Dec 31, 2023
Annual revenue (TTM): $2,965M as of Dec 31, 2023
EBITDA (TTM): $649.10M as of Dec 31, 2023
Net annual income (TTM): $427.20M as of Dec 31, 2023
Free cash flow (TTM): $213.80M as of Dec 31, 2023
Net Debt Last Fiscal Year: $793.20M as of Dec 31, 2023
Shares outstanding: 137,671,143 as of Feb 25, 2024
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.